Literature DB >> 23795964

Chelation therapy: overlooked in the treatment and prevention of diabetes complications?

Norma Frizzell, John W Baynes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23795964     DOI： 10.4155/fmc.13.73

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  11 in total

1.  EDTA chelation therapy alone and in combination with oral high-dose multivitamins and minerals for coronary disease: The factorial group results of the Trial to Assess Chelation Therapy.

Authors:  Gervasio A Lamas; Robin Boineau; Christine Goertz; Daniel B Mark; Yves Rosenberg; Mario Stylianou; Theodore Rozema; Richard L Nahin; L Terry Chappell; Lauren Lindblad; Eldrin F Lewis; Jeanne Drisko; Kerry L Lee
Journal:  Am Heart J       Date:  2014-04-02       Impact factor: 4.749

2.  Advanced glycation in diabetes, aging and age-related diseases: editorial and dedication.

Authors:  Vincent M Monnier; Naoyuki Taniguchi
Journal:  Glycoconj J       Date:  2016-07-15       Impact factor: 2.916

3.  The effect of an EDTA-based chelation regimen on patients with diabetes mellitus and prior myocardial infarction in the Trial to Assess Chelation Therapy (TACT).

Authors:  Esteban Escolar; Gervasio A Lamas; Daniel B Mark; Robin Boineau; Christine Goertz; Yves Rosenberg; Richard L Nahin; Pamela Ouyang; Theodore Rozema; Allan Magaziner; Richard Nahas; Eldrin F Lewis; Lauren Lindblad; Kerry L Lee
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-11-19

4.  The trial to assess chelation therapy 2 (TACT2): Rationale and design.

Authors:  Gervasio A Lamas; Kevin J Anstrom; Ana Navas-Acien; Robin Boineau; Hwasoon Kim; Yves Rosenberg; Mario Stylianou; Teresa L Z Jones; Bonnie R Joubert; Regina M Santella; Esteban Escolar; Y Wady Aude; Vivian Fonseca; Thomas Elliott; Eldrin F Lewis; Michael E Farkouh; David M Nathan; Ana C Mon; Leigh Gosnell; Jonathan D Newman; Daniel B Mark
Journal:  Am Heart J       Date:  2022-05-19       Impact factor: 5.099

Review 5.  Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.

Authors:  Gervasio A Lamas; Ana Navas-Acien; Daniel B Mark; Kerry L Lee
Journal:  J Am Coll Cardiol       Date:  2016-05-24       Impact factor: 24.094

Review 6.  Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients.

Authors:  Gervasio A Lamas; Omar M Issa
Journal:  Curr Cardiol Rep       Date:  2016-02       Impact factor: 2.931

Review 7.  Chelation therapy to treat atherosclerosis, particularly in diabetes: is it time to reconsider?

Authors:  Gervasio A Lamas; Ian Ergui
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-05-05

Review 8.  Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.

Authors:  Rossana Calderon Moreno; Ana Navas-Acien; Esteban Escolar; David M Nathan; Jonathan Newman; John F Schmedtje; Denisse Diaz; Gervasio A Lamas; Vivian Fonseca
Journal:  J Clin Endocrinol Metab       Date:  2019-07-01       Impact factor: 6.134

9.  Possible differential benefits of edetate disodium in post-myocardial infarction patients with diabetes treated with different hypoglycemic strategies in the Trial to Assess Chelation Therapy (TACT).

Authors:  Esteban Escolar; Francisco Ujueta; Hwasoon Kim; Daniel B Mark; Robin Boineau; Richard L Nahin; Christine Goertz; Kerry L Lee; Kevin J Anstrom; Gervasio A Lamas
Journal:  J Diabetes Complications       Date:  2020-05-07       Impact factor: 3.219

10.  Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.

Authors:  Marilia Brito Gomes; Carlos Antonio Negrato
Journal:  Diabetol Metab Syndr       Date:  2014-07-28       Impact factor: 3.320
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.